More News
View News by News Source
Dr Reddys Share Price Live Updates: Dr. Reddy's Laboratories shows strong market interest
ICICI Bank Share Price Live Updates: ICICI Bank Volume Analysis
Bajaj Finance Share Price Live Updates: Bajaj Finance Volume Analysis
JSW Steel Share Price Live Updates: JSW Steel Sees Increased Trading Activity
Tata Consumer Share Price Live Updates: Tata Consumer's Trading Volume Overview
Infosys Share Price Live Updates: Infosys Trading Volume Insights
M&M Share Price Live Updates: M&M trading volume report
SBI Share Price Live Updates: SBI Market Activity
Sun Pharma Share Price Live Updates: Sun Pharma's Recent Trading Volume
Titan Company Share Price Live Updates: Titan Company trading volume analysis
L&T Share Price Live Updates: L&T Market Activity Update
Divis Labs Share Price Live Updates: Divis Labs trading activity summary
HCL Tech Share Price Live Updates: HCL Tech Volume Analysis
SBI Life Share Price Live Updates: SBI Life's Trading Volume Insights
Hindalco Share Price Live Updates: Hindalco's Trading Volume Overview
Apollo Hospital Share Price Live Updates: Apollo Hospital's Volume Statistics
UPL Share Price Live Updates: UPL Sees Significant Trading Activity
BoM's OFS draws bids 400% of base issue size
Bank of Maharashtra's offer for sale saw robust investor demand on its opening day, with bids exceeding 400% of the base issue size. The government will now exercise its green-shoe option, expanding the total stake on offer to 6% after the strong response from non-retail investors.
Insurance firms cut stakes in these 10 Largecap stocks during September quarter
Insurance firms cut their holdings in several NSE largecap stocks from June to September 25, signalling cautious sentiment or portfolio rebalancing. Key companies with reduced insurance shareholding include BPCL, Eicher Motors, TVS Motor, Vedanta, Apollo Hospitals, Grasim, M&M, L&T, Bank of Baroda, and Info Edge.
Wockhardt shares jump over 4%, extend two-day rally following FDA nod for Zaynich
Wockhardt Ltd shares jumped over 4% to 1,533, extending a two-day rally after surging nearly 20% on Tuesday. The rise follows the US FDAs acceptance of its New Drug Application for Zaynich, a first-in-class antibiotic, marking the first NDA approval for a New Chemical Entity by an Indian pharma company.
China stocks attract fund managers amid economic uncertainty
Global fund managers are steadily returning to China as strong market gains, attractive valuations and rising inflows bolster confidence despite ongoing economic uncertainty.
